Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea · Delayed Price · Currency is KRW 6,650.00
-100.00 (-1.48%)
Sep 18, 2025, 2:40 PM KST
Komipharm International Market Cap
Komipharm International has a market cap or net worth of 484.75 billion as of September 17, 2025. Its market cap has increased by 69.76% in one year.
Market Cap
484.75B
Enterprise Value
507.65B
Revenue
54.81B
Ranking
n/a
PE Ratio
115.33
Stock Price
6,650.00
Market Cap Chart
Since March 1, 2002, Komipharm International's market cap has increased from 94.26B to 484.75B, an increase of 414.26%. That is a compound annual growth rate of 7.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 484.75B | 81.27% |
| Dec 30, 2024 | 267.41B | -9.03% |
| Dec 28, 2023 | 293.94B | -34.10% |
| Dec 29, 2022 | 446.06B | -18.67% |
| Dec 30, 2021 | 548.45B | -36.13% |
| Dec 30, 2020 | 858.75B | -11.44% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.60T |
| Celltrion | 37.10T |
| ALTEOGEN | 25.28T |
| Yuhan | 8,693.59B |
| SK Biopharmaceuticals | 8,410.84B |
| Peptron | 6,744.58B |
| PharmaResearch | 6,431.19B |
| ABL Bio | 5,452.05B |